PLSE

NEUTRALAnalyst

Pulse Biosciences, Inc

2026-09-11

Price

$53.11

-2.43%

This is the 2026-09-11 snapshot — the signals and analysis for PLSE as of this single trading day.

View full PLSE research hub →

Score1.1Noise

Signals3/8 DNA0/13 Act · 2/4 Risk

SentimentNEUTRALScore: 8

Volume1.1xvs 20d avg

Analysis

Pulse Biosciences (PLSE) is exhibiting High-Conviction Price Discovery, driven by a fresh 'Strong-Buy' upgrade from Freedom Capmkts amid a highly supportive RISK_ON macro regime. Despite minor intraday profit-taking, the stock's PERFECT_STACK and MARKET_LEADER signals underscore robust institutional sponsorship, pushing it 62% higher over the last month. With credit markets ignoring hawkish CPI data and HY OAS tightening, high-beta momentum names like PLSE are perfectly positioned to absorb short-term selling pressure and continue their breakout trajectory.

Fired Signals

GOLDEN CROSSMARKET LEADERPERFECT STACKEXTENSIONDISTRIBUTION

Key Takeaways

Actionable Thesis: PLSE is a high-beta momentum leader supported by a new analyst upgrade and a macro environment that heavily rewards risk-taking.
Key Risk: Extreme annualized volatility (89.2%) and headline-driven profit-taking could trigger sharp intraday drawdowns.
What to Watch: Monitor the $34.25 structural support level and volume patterns to ensure institutional absorption continues during minor pullbacks.

← Back to 2026-09-11 View Full PLSE History →Yahoo Finance &nearr;